252 related articles for article (PubMed ID: 33426818)
1. PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity.
Goel PN; Grover P; Greene MI
Crit Rev Immunol; 2020; 40(4):283-295. PubMed ID: 33426818
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases.
Jain K; Jin CY; Clarke SG
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10101-10106. PubMed ID: 28874563
[TBL] [Abstract][Full Text] [Related]
3. PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185
Nagai Y; Ji MQ; Zhu F; Xiao Y; Tanaka Y; Kambayashi T; Fujimoto S; Goldberg MM; Zhang H; Li B; Ohtani T; Greene MI
Front Immunol; 2019; 10():174. PubMed ID: 30800128
[TBL] [Abstract][Full Text] [Related]
4. PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination.
Clarke TL; Sanchez-Bailon MP; Chiang K; Reynolds JJ; Herrero-Ruiz J; Bandeiras TM; Matias PM; Maslen SL; Skehel JM; Stewart GS; Davies CC
Mol Cell; 2017 Mar; 65(5):900-916.e7. PubMed ID: 28238654
[TBL] [Abstract][Full Text] [Related]
5. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
6. CARM1-mediated methylation of protein arginine methyltransferase 5 represses human γ-globin gene expression in erythroleukemia cells.
Nie M; Wang Y; Guo C; Li X; Wang Y; Deng Y; Yao B; Gui T; Ma C; Liu M; Wang P; Wang R; Tan R; Fang M; Chen B; He Y; Huang DCS; Ju J; Zhao Q
J Biol Chem; 2018 Nov; 293(45):17454-17463. PubMed ID: 30257864
[TBL] [Abstract][Full Text] [Related]
7. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
8. Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review).
Wu K; Niu C; Liu H; Fu L
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37026519
[TBL] [Abstract][Full Text] [Related]
9. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
Fulton MD; Dang T; Brown T; Zheng YG
Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
[TBL] [Abstract][Full Text] [Related]
10. Genome wide comparative analysis of the effects of PRMT5 and PRMT4/CARM1 arginine methyltransferases on the Arabidopsis thaliana transcriptome.
Hernando CE; Sanchez SE; Mancini E; Yanovsky MJ
BMC Genomics; 2015 Mar; 16(1):192. PubMed ID: 25880665
[TBL] [Abstract][Full Text] [Related]
11. PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.
Chiang K; Zielinska AE; Shaaban AM; Sanchez-Bailon MP; Jarrold J; Clarke TL; Zhang J; Francis A; Jones LJ; Smith S; Barbash O; Guccione E; Farnie G; Smalley MJ; Davies CC
Cell Rep; 2017 Dec; 21(12):3498-3513. PubMed ID: 29262329
[TBL] [Abstract][Full Text] [Related]
12. ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer.
Im H; Baek HJ; Yang E; Kim K; Oh SK; Lee JS; Kim H; Lee JM
Cancer Sci; 2023 Jan; 114(1):187-200. PubMed ID: 36114756
[TBL] [Abstract][Full Text] [Related]
13. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
Stopa N; Krebs JE; Shechter D
Cell Mol Life Sci; 2015 Jun; 72(11):2041-59. PubMed ID: 25662273
[TBL] [Abstract][Full Text] [Related]
14. Human protein arginine methyltransferases (PRMTs) can be optimally active under nonphysiological conditions.
Lowe TL; Clarke SG
J Biol Chem; 2022 Sep; 298(9):102290. PubMed ID: 35868559
[TBL] [Abstract][Full Text] [Related]
15. PRMT5 regulates epigenetic changes in suppressive Th1-like iTregs in response to IL-12 treatment.
Jadon N; Shanthalingam S; Tew GN; Minter LM
Front Immunol; 2023; 14():1292049. PubMed ID: 38259494
[TBL] [Abstract][Full Text] [Related]
16. Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.
Ma D; Yang M; Wang Q; Sun C; Shi H; Jing W; Bi Y; Shen X; Ma X; Qin Z; Lin Y; Zhu L; Zhao Y; Cheng Y; Han L
Sci Adv; 2021 Mar; 7(13):. PubMed ID: 33762328
[TBL] [Abstract][Full Text] [Related]
17. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
18. Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
Liu S; Liu Z; Piao C; Zhang Z; Kong C; Yin L; Liu X
J Exp Clin Cancer Res; 2022 Oct; 41(1):293. PubMed ID: 36199122
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1
Zheng Y; Chen Z; Zhou B; Chen S; Han L; Chen N; Ma Y; Xie G; Yang J; Nie H; Shen L
J Immunol; 2022 Jan; 208(2):501-513. PubMed ID: 34911774
[TBL] [Abstract][Full Text] [Related]
20. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.
Shailesh H; Zakaria ZZ; Baiocchi R; Sif S
Oncotarget; 2018 Nov; 9(94):36705-36718. PubMed ID: 30613353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]